Andere talen DMK Pharmaceuticals Corporation

Aandelen

DMKPQ

US00547W3079

Vertraagde tijd OTC Markets Andere beurzen 21:52:21 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,05 ^USD	+50,15%		+42,86%	-92,86%

06/02	Motie voor gezamenlijk beheer goedgekeurd voor DMK Pharmaceuticals Corporation	CI
02/02	Motie voor gezamenlijk beheer ingediend door DMK Pharmaceuticals Corporation	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	11/04
North American Morning Briefing : Focus Turns to -2-	04/04
Bidding Procedure Approved for DMK Pharmaceuticals Corporation	04/04
Motion for Asset Sale Filed by DMK Pharmaceuticals Corporation	21/03
DMK Pharmaceuticals Corporation(NasdaqCM:DMK) dropped from S&P TMI Index	08/02
Motion for Joint Administration Approved for DMK Pharmaceuticals Corporation	06/02
DMK Pharmaceuticals Corporation(OTCPK:DMKP.Q) dropped from NASDAQ Composite Index	06/02
DMK Pharmaceuticals Commences Restructuring Proceeding	03/02
Motion for Joint Administration Filed by DMK Pharmaceuticals Corporation	02/02
DMK Pharmaceuticals Corporation Filed for Bankruptcy	02/02
DMK Pharmaceuticals Corporation Announces Board Appointments	31/01
DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI	21/12
DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update	28/11
DMK Pharmaceuticals Corporation Regains Full Rights from US WorldMeds for SYMJEPI	28/11
DMK Pharmaceuticals Corporation(OTCPK:DMKP.Q) added to NASDAQ Composite Index	21/11
Adamis Pharmaceuticals Corporation(NasdaqCM:ADMP) dropped from NASDAQ Composite Index	20/11
DMK Pharmaceuticals: Q3 Earnings Snapshot	14/11
Earnings Flash (DMK) DMK PHARMACEUTICALS CORPORATION Reports Q3 Revenue $9,062	14/11
DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update	14/11
DMK Pharmaceuticals Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen DMK Pharmaceuticals Corporation

Aandelen

DMKPQ

US00547W3079

Andere talen

Filters